retatrutide and muscle loss Side Effects: Loss, Dosing Risks Protocol Lilly's retatrutide shows 28% weight

Because Retatrutide is still investigational, long-term safety especially outside controlled trials remains less certain

Stomach Speed: It slows down how fast food leaves your stomach, so you feel full for a longer time after eating

Retatrutide's GLP-1 affinity is the floor of the stack most of the early appetite suppression in the first 4-8 weeks is reportedly GLP-1-mediated

One that is in late-stage trials but is already getting lots of headlines is retatrutide

After 68 weeks, half of the participants taking Semaglutide GLP-1 had lost 15 percent of their body weight, and nearly a third had lost 20 percent

Close Monitoring and Follow-Up Regular visits to assess progress, adjust dosing and manage side effects